Cécile Orsini

Title: Cécile Orsini: Innovator in Recombinant Adenoviruses

Introduction

Cécile Orsini is a prominent inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant adenoviruses. His innovative work has implications for gene therapy and pharmaceutical compositions.

Latest Patents

Cécile Orsini holds a patent for "Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses." This patent describes a recombinant adenovirus in which the expression of a nucleic acid sequence coding for at least one homologous or heterologous gene of viral origin is placed under the control of an inducible promoter. The patent also covers the use of such recombinant adenoviruses for preparing AAVs, as well as a complementary cell line and preparation method. Furthermore, it includes pharmaceutical compositions containing this adenovirus.

Career Highlights

Throughout his career, Cécile Orsini has worked with notable companies in the pharmaceutical industry, including Aventis Pharma S.A. and Genzyme Corporation. His experience in these organizations has allowed him to advance his research and contribute to significant innovations in the field.

Collaborations

Cécile has collaborated with esteemed colleagues such as Michel Perricaudet and Martine Latta. These partnerships have fostered a collaborative environment that has enhanced the development of his innovative projects.

Conclusion

Cécile Orsini's work in recombinant adenoviruses showcases his dedication to advancing biotechnology. His contributions have the potential to impact gene therapy and pharmaceutical development significantly.